Search Tag: Research
New Study to Evaluate Biotronik’s Combined Pulsar/Passeo Balloon in Treating SFA
2014 18 Jul
BIOLUX 4EVER Study Aims to Build on Positive Results of BIOLUX P-I and 4EVER Trials BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, has announced that the first patient has been enrolled in the investigator-initiated BIOLUX 4EVER trial. Given the positive results from each of the previous drug releasing balloon... Read more
Simple Prediction Tool For Out-Of-Hospital Cardiac Arrest Survivors
2014 15 Jul
Out-of-hospital cardiac arrest is one of the major health problems in the world, with a global incidence of 55 adult out-of-hospital cardiac arrests per 100,000 person-years and a poor survival rate of between 2% and 11%. A recent study aimed to develop an accurate outcome-prediction tool for patients after cardiac arrest. Accurate risk prediction... Read more
Beta-Blockers: No Improved Outcomes for Heart Bypass Patients
2014 18 Jun
A new retrospective analysis of patient data suggests that the preoperative use of beta-blockers does not improve outcomes for all patients who undergo nonemergency coronary artery bypass grafting (CABG) surgery. Patients who had not experienced a heart attack in the three weeks prior to surgery, and who did not exhibit other high-risk symptoms, had... Read more
Cardiac Biomarkers Predict Diabetes Complications
2014 10 Jun
University of Glasgow researchers have found that some microvascular complications of Type 2 diabetes can be predicted by an assessment of cardiac biomarkers. The results indicate that an underlying cardiac condition may precede peripheral microvascular disease processes. Peripheral microvascular events common to diabetic patients include nephropathy... Read more
Hidden Incidence of Diabetes In Heart Attack Patients
2014 10 Jun
Recent research has exposed the frequency of undiagnosed, and consequently untreated, cases of diabetes in patients admitted to hospital due to acute myocardial infarction (MI). While plenty of practice guidelines exist for the treatment of patients who present with both MI and diabetes, most fail to address the issue of incident diabetes screening... Read more
Cardiovascular Research Centre Opens in Leicester
2014 10 Jun
The University of Leicester British Heart Foundation Cardiovascular Research Centre (CRC) officially opens on 11 June 2014 at Glenfield Hospital in Leicester. The new facility brings together a world-renowned team of heart scientists who will have access to advanced IT systems and equipment, benefitting patients and raising the reputation of Leicester... Read more
'Heart Disease-on-a-Chip' Modelled From Patient Stem Cells
2014 14 May
By merging stem cell and 'organ-on-a-chip' technologies Harvard scientists have, in a world premiere, successfully grown functioning human heart tissue that carries an inherited cardiovascular disease. A major development for personalised medicine, this research, which was published in Nature Medicine, provides working proof that laboratory-based... Read more
The Lower Your Status, The Higher Your Risk of High Blood Pressure
2014 14 May
Social status is related to risk of high blood pressure, according to researchers from the Medical University of Vienna. Anita Rieder and Thomas Dorner from the Institute of Social Medicine in Vienna analysed international and national data on the socio-demographic aspects of hypertension. They found that variables such as education, income, employment,... Read more
Cardiac Hypertrophy: Preventable via Protein
2014 13 May
As cardiovascular disease remains the Western world’s leading cause of death, heart failure is the category registering the fastest incidence increase over the past ten years. Pathological hypertrophy, defined as the heart muscle’s growth as its attempt to increase its output, is the stage that precedes heart failure, yet not all hypertrophy... Read more
Antihypertensive ACEIs Linked to Reduction in Cardiovascular Events, Death
2014 01 Apr
According to findings of a study published in the March 31 online edition of JAMA Internal Medicine, the use of blood pressure medication angiotensin-converting enzyme inhibitors (ACEIs) in patients with diabetes seems to contribute to a reduction of major cardiovascular events and death, as well death from all other causes, while angiotensin II receptor... Read more